Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05912244
What this trial is testing

IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 43
Testing effectiveness (Phase 2)Ended earlyNCT00706992
What this trial is testing

Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients

Who this might be right for
Melanoma
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT01827111
What this trial is testing

Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 21
Post-approval studies (Phase 4)UnknownNCT03313544
What this trial is testing

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Who this might be right for
MelanomaNon-small CellLung Cancer
Assistance Publique Hopitaux De Marseille 50
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableStudy completedNCT02431572
What this trial is testing

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

Who this might be right for
Intracranial TumorsGlioblastomaMelanoma
Massachusetts General Hospital 11
Testing effectiveness (Phase 2)Study completedNCT05282901
What this trial is testing

Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)

Who this might be right for
Metastatic Uveal Melanoma
Institut Curie 51
Early research (Phase 1)Active Not RecruitingNCT04336241
What this trial is testing

Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors

Who this might be right for
Cancer
Replimune, Inc. 36
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Not applicableStudy completedNCT03581357
What this trial is testing

Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors

Who this might be right for
Cancer, Other Than Non-melanoma Skin Cancer
University of Hawaii 302
Testing effectiveness (Phase 2)UnknownNCT05602792
What this trial is testing

T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorSarcomaHNSCC+4 more
ImmVira Pharma Co. Ltd 233
Testing effectiveness (Phase 2)Study completedNCT01100528
What this trial is testing

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+1 more
Case Comprehensive Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT02807844
What this trial is testing

Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies

Who this might be right for
Triple Negative Breast CancerPancreatic CarcinomaMelanoma+1 more
Novartis Pharmaceuticals 141
Testing effectiveness (Phase 2)Active Not RecruitingNCT04083599
What this trial is testing

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Who this might be right for
Malignant Solid TumorNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+3 more
Genmab 350
Not applicableStudy completedNCT07427953
What this trial is testing

Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma

Who this might be right for
Malignant MelanomaDrug-Induced Retinopathy
Institute of Oncology Ljubljana 14
Early research (Phase 1)Ended earlyNCT02543645
What this trial is testing

Varlilumab and Atezolizumab in Patients With Advanced Cancer

Who this might be right for
Carcinoma, Renal CellKidney DiseasesKidney Neoplasms+11 more
Celldex Therapeutics 18
Testing effectiveness (Phase 2)Study completedNCT00436930
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Hoag Memorial Hospital Presbyterian 200
Not applicableStudy completedNCT02416336
What this trial is testing

Evaluation of Intraoperative Usage of Sentinella in Detecting Sentinel Lymph Nodes

Who this might be right for
MelanomaHead and Neck CancerBreast Cancer
Oncovision Inc 100
Not applicableLooking for participantsNCT07415564
What this trial is testing

Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers

Who this might be right for
Cancer MetastaticSymptoms and SignsQuality of Life
University of Arizona 200
Not applicableNot Yet RecruitingNCT07293598
What this trial is testing

Investigation of the ROle of faT and inflAmmaTory Cells in mElanoma

Who this might be right for
Melanoma (Skin Cancer)
The Christie NHS Foundation Trust 20
Next Page